Brisbane Angels

Upcoming Events 

Screening Meeting - QA Hotel 13th November

Members Meeting - QA Hotel 13th November

AAAI National Conference - Gold Coast 20-22 February 2013 brochure website

Company A - a specialty pharmaceutical company developing proprietary technology for the control of invertebrate pests with significant human pharmaceutical and veterinary applications.

This is a co-investment opportunity with a consortium of VCs.

Company B - is the only company in the world today which focusses solely on software for the hotel housekeeping function. They count Hyatt, Marriott, Shangri-La, Four Seasons and Kempinski among their clients across 3 continents. Producing the product in-house with a development team in Vietnam, they manage reseller channels for sales and service, underpinned by direct sales to regional and global hotel head offices.

This is a subsquent round to fund USA market penetration.

Company C  -  is commercilaising a proprietary microencapsulation technology. We are using this technology to create novel food and nutraceutical ingredients which can be used to create new functional foods, beverages and supplements.

This is a subsquent funding round.

Company D - (USA Based) - whose product addresses consumer behaviors including snacking, eating alone, globalization of food and families not eating the same kind of meals they once did. One-third of Americans are replacing meals with smaller snack-sized meals. Our products address all of the current market demands and are ideal for the on-the-go American who wants covenience and health.

This is a co-investment opportunity with USA angel groups.